Table 2.

Global Measures of Systolic Function and Remodeling from MRI Data

	Placebo		G-CSF		BM
	Pre-IC Rx	6 Wk FU	Pre-IC Rx	6 Wk FU	Pre-IC Rx	6 Wk FU
	n=6	n=6	n=6	n=5	n=6	n=5
EF (%)	34.3±9.7	26.5±6.8*	31.2±7.8	24.3±5.1*	40.4±6.0	29.6±8.1*
ESV (mL)	56.5±18.4	69.2±14.1*	49.5±12.2	72.3±12.9*	35.7±11.3	52.9±22.8*
EDV (mL)	84.2±16.0	93.9±14.8†	72.1±15.7	95.8±19.2†	60.1±16.7	73.4±23.7†
SV (mL)	27.7±4.1	24.7±6.3	22.6±7.2	23.7±8.5	24.2±6.9	20.5±3.9
LVM (g)	80.1±11.2	80.7±6.2	68.6±13.8	79.5±12.1	83.0±8.7	81.7±12.0

EF – ejection fraction; EDV – end-diastolic volume; ESV – end-systolic volume; SV – stroke volume; LVM – left ventricular mass; Pre-IC Rx – Pre-Intracoronary Cell Infusion; 6Wk FU – 6 Week Follow-up.

^*p<0.01 v pre-IC Rx;

^†p<0.05 v pre-IC Rx.